DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Debiec-Rychter M, Dumez H, Judson I, Wasag B, Verweij J, Brown M, Dimitrijevic S, Sciot R, Stul M, Vranck H, Scurr M, Hagemeijer A, van Glabbeke M, vanOsteroom AT.
Use of c-kit/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.
Eur J Cancer 2004; 40: 689-695
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.